Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Analysis of blood-based gene expression in idiopathic Parkinson disease.

Shamir R, Klein C, Amar D, Vollstedt EJ, Bonin M, Usenovic M, Wong YC, Maver A, Poths S, Safer H, Corvol JC, Lesage S, Lavi O, Deuschl G, Kuhlenbaeumer G, Pawlack H, Ulitsky I, Kasten M, Riess O, Brice A, Peterlin B, Krainc D.

Neurology. 2017 Oct 17;89(16):1676-1683. doi: 10.1212/WNL.0000000000004516. Epub 2017 Sep 15.

2.

Mathematical Modeling Reveals That Changes to Local Cell Density Dynamically Modulate Baseline Variations in Cell Growth and Drug Response.

Greene JM, Levy D, Herrada SP, Gottesman MM, Lavi O.

Cancer Res. 2016 May 15;76(10):2882-90. doi: 10.1158/0008-5472.CAN-15-3232. Epub 2016 Mar 1.

3.

Thermodynamic and kinetic studies of LiNi0.5Co0.2Mn0.3O2 as a positive electrode material for Li-ion batteries using first principles.

Dixit M, Kosa M, Lavi OS, Markovsky B, Aurbach D, Major DT.

Phys Chem Chem Phys. 2016 Mar 7;18(9):6799-812. doi: 10.1039/c5cp07128c. Epub 2016 Feb 15.

PMID:
26878345
4.

Toward a Better Understanding of the Complexity of Cancer Drug Resistance.

Gottesman MM, Lavi O, Hall MD, Gillet JP.

Annu Rev Pharmacol Toxicol. 2016;56:85-102. doi: 10.1146/annurev-pharmtox-010715-103111. Epub 2015 Oct 28. Review.

PMID:
26514196
5.

Redundancy: a critical obstacle to improving cancer therapy.

Lavi O.

Cancer Res. 2015 Mar 1;75(5):808-12. doi: 10.1158/0008-5472.CAN-14-3256. Epub 2015 Jan 9.

6.

Modeling intrinsic heterogeneity and growth of cancer cells.

Greene JM, Levy D, Fung KL, Souza PS, Gottesman MM, Lavi O.

J Theor Biol. 2015 Feb 21;367:262-277. doi: 10.1016/j.jtbi.2014.11.017. Epub 2014 Nov 29.

7.

Network features suggest new hepatocellular carcinoma treatment strategies.

Lavi O, Skinner J, Gottesman MM.

BMC Syst Biol. 2014 Jul 29;8:88. doi: 10.1186/s12918-014-0088-0.

8.

The impact of cell density and mutations in a model of multidrug resistance in solid tumors.

Greene J, Lavi O, Gottesman MM, Levy D.

Bull Math Biol. 2014 Mar;76(3):627-53. doi: 10.1007/s11538-014-9936-8. Epub 2014 Feb 20.

9.

Simplifying the complexity of resistance heterogeneity in metastasis.

Lavi O, Greene JM, Levy D, Gottesman MM.

Trends Mol Med. 2014 Mar;20(3):129-36. doi: 10.1016/j.molmed.2013.12.005. Epub 2014 Jan 31.

10.

The role of cell density and intratumoral heterogeneity in multidrug resistance.

Lavi O, Greene JM, Levy D, Gottesman MM.

Cancer Res. 2013 Dec 15;73(24):7168-75. doi: 10.1158/0008-5472.CAN-13-1768. Epub 2013 Oct 25.

11.

Network-induced classification kernels for gene expression profile analysis.

Lavi O, Dror G, Shamir R.

J Comput Biol. 2012 Jun;19(6):694-709. doi: 10.1089/cmb.2012.0065.

12.

The dynamics of drug resistance: a mathematical perspective.

Lavi O, Gottesman MM, Levy D.

Drug Resist Updat. 2012 Feb-Apr;15(1-2):90-7. doi: 10.1016/j.drup.2012.01.003. Epub 2012 Mar 3. Review.

13.

Regulation of modular Cyclin and CDK feedback loops by an E2F transcription oscillator in the mammalian cell cycle.

Lavi O, Ginsberg D, Louzoun Y.

Math Biosci Eng. 2011 Apr;8(2):445-61. doi: 10.3934/mbe.2011.8.445.

14.

Effect of vaccination in environmentally induced diseases.

Lavi O, Klement E, Louzoun Y.

Bull Math Biol. 2011 May;73(5):1101-17. doi: 10.1007/s11538-010-9554-z. Epub 2010 Jun 17.

15.

Different sets of QTLs influence fitness variation in yeast.

Romano GH, Gurvich Y, Lavi O, Ulitsky I, Shamir R, Kupiec M.

Mol Syst Biol. 2010;6:346. doi: 10.1038/msb.2010.1. Epub 2010 Feb 16.

16.

What cycles the cell? -Robust autonomous cell cycle models.

Lavi O, Louzoun Y.

Math Med Biol. 2009 Dec;26(4):337-59. doi: 10.1093/imammb/dqp016. Epub 2009 Jul 6.

PMID:
19581341
17.

Listeriosis: a model for the fine balance between immunity and morbidity.

Lavi O, Louzoun Y, Klement E.

Epidemiology. 2008 Jul;19(4):581-7. doi: 10.1097/EDE.0b013e3181761f6f.

PMID:
18496469

Supplemental Content

Support Center